Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Hair Relaxer Manufacturers File Motion to Dismiss Master Personal Injury Complaint, As “Traditional” Discovery Gets Underway Manufacturers challenge allegations raised in hundreds of hair relaxer lawsuits brought by women diagnosed with uterine cancer, ovarian cancer and other injuries, as the Court rejected an attempt to bifurcate discovery July 7, 2023 Irvin Jackson Add Your Comments In response to a growing number of hair relaxer lawsuits filed by women diagnosed with uterine cancer, ovarian cancer and other injuries, the makers of Dark & Lovely, Just for Me, Optimum, ORS Olive Oil and other popular hair straighteners have joined together in a motion to dismiss hundreds of claims, arguing that a Master Personal Injury Complaint filed on behalf of all plaintiffs fails to sufficiently identify specific products, formulations or compounds that caused each injury. Thereย are currently about 250 product liability lawsuit filed against LโOrรฉal, Revlon, Strength of Nature, Namaste and other manufacturers, each raising similar allegations that women have not been adequately warned about the link between hair relaxer and cancer. However, lawyers anticipate thousands of additional cases will be brought in the coming weeks and months, given the widespread use of the chemical hair straighteners, which have been specifically marketed as safe for women in the Black community to use for decades. HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised inย Dark & Lovely lawsuits,ย Just For Me lawsuitsย and other claims brought throughout the federal court system, a multidistrict litigation (MDL) was established last year before U.S. District Judge Mary M. Rowland in the Northern District of Illinois. Judge Rowland is now working with the parties to establish a schedule for coordinated discovery and determining when a series of early bellwether trials may be ready to begin, which will help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation. Motion to Dismiss Hair Relaxer Lawsuit Master Complaint In May, plaintiffs submitted a Master Long-Form Complaint to the Court, which is intended to contain all of the allegations raised in various lawsuits, which each individual plaintiff can then adopt by filing a Short-Form Complaint. The process is intended to streamline the filing of new claims, and facilitate pre-trial motions challenging the adequacy of the allegations and claims. This week, all of the hair relaxer manufacturers involved in the litigation joined together to file a motion to dismiss (PDF) the Master Complaint, claiming that plaintiffs failed to sufficiently plead their case, since individual products and formulations were not identified as the cause of each individual injury, and the master complaint fails to lay out what is defective about each of the hair relaxer products. The motion claims many of the brands identified in various hair relaxer lawsuits use different chemical straightening products, as well as non-straightening ingredients. Many of the complaints include a list of products plaintiffs used over the years, such as Dark & Lovely, Optimum and Just for Me, but fail to specifically identify which products caused the injury. โDefendants should not be forced to guess which products were used by Plaintiffs at any given time,โ the motion argues. โPlaintiffs should be required โ as are all other products liability plaintiffs โ to identify the specific product they used that allegedly caused their condition.โ In a Notification of Docket Entry (PDF) filed by Judge Rowland on July 6, the Court indicated it will decide following an August 23 conference whether oral arguments over the motion to dismiss are necessary. Plaintiffs have yet to respond to the motion, and an amended Master complaint may be filed to address issues raised. Hair Relaxer MDL Judge Rejects Bifurcated Discovery Plan During a status conference held before Judge Rowland this week, the parties also discussed how discovery will proceed in the rapidly growing litigation. The Court rejected a prior proposal filed by the manufacturers to bifurcate hair relaxer lawsuit discovery proceedings, which would have prioritized “general causation” discovery before allowing any case specific discovery. Plaintiffs had opposed the plan, arguing it would cause substantial delays in the litigation, dramatically increase costs, and would be inefficient in helping the parties reach a settlement agreement. In a separate docket entry (PDF) entered on July 6, Judge Rowland indicated that the parties should proceed with “traditional” fact discovery, and must meet and confer by July 18, to submit proposed discovery deadlines and when the Court should close fact discovery. During the status conference, the Court also announced it will conduct a โScience Dayโ near the end of fact discovery, which will allow each side to make non-adversarial presentations designed to educate the Judge about complex issues that will arise during the litigation. Judge Rowland indicated that the parties should discuss how to approach the science presentations at a hearing scheduled for November 17. July 2023 Hair Relaxer Lawsuit Update Each of the complaints raise similar allegations, indicating that women were not adequately warned about the toxic side effects of endocrine disrupting chemicals in the products, which have been blamed for cases ofย uterine cancer,ย ovarian cancer,ย uterine fibroidsย and other complications. Following common fact discovery, it is expected that Judge Rowland will establish a bellwether trial program, where a group of representative claims will be prepared for early trial dates to help gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation. While the outcomes of any early bellwether trials will not have any binding impact on other claims, the average hair relaxer injury payouts awarded by juries for different types of injury, and against the manufacturers of different specific products, is expected to have a large impact on the amounts of any settlement offers that may be made to avoid the need for each individual case to go before a jury. If the parties fail to negotiate hair relaxer injury settlements following the MDL proceedings before Judge Rowland, each claim may later be remanded back to the U.S. District Court where it originally would have been brought for future trial dates. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Dark & Lovely, Endocrine Disruptors, Endometriosis, Hair Relaxer, Hair Straighteners, Just for Me, L'Oreal, Optimum, Perm, Phthalates, Uterine Cancer, Uterine Fibroids Image Credit: Kelly Heck Photography Find Out If You Qualify for Hair Relaxer Compensation More Hair Relaxer Lawsuit Stories Hair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials March 23, 2026 Lawyers To Nominate Hair Relaxer Cancer Cases for Early Bellwether Trials Next Week March 12, 2026 Court Outlines Procedures When Women Die After Filing a Hair Relaxer Cancer Lawsuit February 25, 2026 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Infections After Colonoscopy, ERCP May Result in Lawsuits Over Olympus Scope Problems (Posted: today) Patients are developing serious infections after colonoscopy and ERCP procedures, as concerns grow that reusable endoscopes may not be fully sterilized, leading to new lawsuits over contaminated medical devices. MORE ABOUT: SCOPE INFECTION LAWSUIT Drug Makers Agree Dupixent Cancer Lawsuits Should Be Centralized in MDL (Posted: yesterday) Regeneron and Sanofi-Aventis agree with calls to consolidate all Dupixent cancer lawsuits currently spread throughout the federal court system before one judge. MORE ABOUT: DUPIXENT LAWSUITEnlarged Lymph Nodes Led to Dupixent CTCL Diagnosis, Lawsuit Claims (03/16/2026)Dupixent Mycosis Fungoides Lawsuit Filed Over Failure To Warn About T-Cell Lymphoma Risks (03/09/2026)Dupixent Caused T-Cell Lymphoma or Rapidly Progressed Cancer, Lawsuit Alleges (02/25/2026) Depo-Provera Meningioma Lawyers Reappointed to MDL Leadership Roles (Posted: 2 days ago) A group of about 70 Depo-Provera meningioma lawyers have been reappointed to key leadership roles in the litigation, as thousands of women seek compensation for brain tumors they say were caused by the birth control shots. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Symptoms Reported Among Birth Control Users (03/19/2026)Depo Injection Lawsuit Claims Birth Control Shot Caused Meningioma Brain Tumor (03/17/2026)Nearly 4,000 Women Are Pursuing a Depo-Provera Lawsuit After Developing Brain Tumors (03/04/2026)
Hair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials March 23, 2026
Court Outlines Procedures When Women Die After Filing a Hair Relaxer Cancer Lawsuit February 25, 2026
Infections After Colonoscopy, ERCP May Result in Lawsuits Over Olympus Scope Problems (Posted: today) Patients are developing serious infections after colonoscopy and ERCP procedures, as concerns grow that reusable endoscopes may not be fully sterilized, leading to new lawsuits over contaminated medical devices. MORE ABOUT: SCOPE INFECTION LAWSUIT
Drug Makers Agree Dupixent Cancer Lawsuits Should Be Centralized in MDL (Posted: yesterday) Regeneron and Sanofi-Aventis agree with calls to consolidate all Dupixent cancer lawsuits currently spread throughout the federal court system before one judge. MORE ABOUT: DUPIXENT LAWSUITEnlarged Lymph Nodes Led to Dupixent CTCL Diagnosis, Lawsuit Claims (03/16/2026)Dupixent Mycosis Fungoides Lawsuit Filed Over Failure To Warn About T-Cell Lymphoma Risks (03/09/2026)Dupixent Caused T-Cell Lymphoma or Rapidly Progressed Cancer, Lawsuit Alleges (02/25/2026)
Depo-Provera Meningioma Lawyers Reappointed to MDL Leadership Roles (Posted: 2 days ago) A group of about 70 Depo-Provera meningioma lawyers have been reappointed to key leadership roles in the litigation, as thousands of women seek compensation for brain tumors they say were caused by the birth control shots. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Symptoms Reported Among Birth Control Users (03/19/2026)Depo Injection Lawsuit Claims Birth Control Shot Caused Meningioma Brain Tumor (03/17/2026)Nearly 4,000 Women Are Pursuing a Depo-Provera Lawsuit After Developing Brain Tumors (03/04/2026)